09434746 is referenced by 2 patents and cites 281 patents.

The present invention provides pyrimidinones that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

Title
Pyrimidinones as PI3K inhibitors
Application Number
14/146169
Publication Number
9434746 (B2)
Application Date
January 2, 2014
Publication Date
September 6, 2016
Inventor
Andrew P Combs
Kennett Square
PA, US
Brian W Metcalf
Moraga
CA, US
Yun Long Li
Chadds Ford
PA, US
Agent
Fish & Richardson P C
Assignee
Incyte Holdings Corporation
DE, US
Incyte Corporation
DE, US
IPC
C07D 519/00
C07D 487/04
C07D 471/04
C07D 513/04
View Original Source